Literature DB >> 14694143

Isoform specificity of human Na(+), K(+)-ATPase localization and aldosterone regulation in mouse kidney cells.

Vanessa Summa1, Simone M R Camargo, Christian Bauch, Marija Zecevic, François Verrey.   

Abstract

Short-term aldosterone coordinately regulates the cell-surface expression of luminal epithelial sodium channels (ENaC) and of basolateral Na(+) pumps (Na(+), K(+)-ATPase alpha1-beta1) in aldosterone-sensitive distal nephron (ASDN) cells. To address the question of whether the subcellular localization of the Na(+), K(+)-ATPase and its regulation by aldosterone depend on subunit isoform-specific structures, we expressed the cardiotonic steroid-sensitive human alpha isoforms 1-3 by retroviral transduction in mouse collecting duct mpkCCD(c14) cells. Each of the three exogenous human isoforms could be detected by Western blotting. Immunofluorescence indicated that the exogenous alpha1 subunit to a large extent localizes to the basolateral membrane or close to it, whereas much of the alpha2 subunit remains intracellular. An ouabain-sensitive current carried by exogenous pumps could be detected in apically amphotericin B-permeabilized epithelia expressing human alpha1 and alpha2 subunits, but not the alpha3 subunit. This current displayed a higher apparent Na(+) affinity in pumps containing human alpha2 subunits (10 mM) than in pumps containing human alpha1 (33.2 mM) or endogenous (cardiotonic steroid-resistant) mouse alpha1 subunits (mean: 16.3 mM). A very low mRNA level of the Na(+), K(+)-ATPase gamma subunit (FXYD2) in mpkCCD(c14) cells suggested that this ancillary gene product is not responsible for the relatively low apparent Na(+) affinity measured for a1 subunit-containing pumps. Aldosterone increased the pump current carried by endogenous pumps and by pumps containing the human alpha1 subunit. In contrast, the current carried by pumps with a human alpha2 subunit was not stimulated by the same treatment. In summary, quantitative basolateral localization of the Na(+), K(+)-ATPase and its responsiveness to aldosterone require alpha1 subunit-specific sequences that differentiate this isoform from the alpha2 and alpha3 subunit isoforms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694143      PMCID: PMC1664841          DOI: 10.1113/jphysiol.2003.054270

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Distribution and oligomeric association of splice forms of Na(+)-K(+)-ATPase regulatory gamma-subunit in rat kidney.

Authors:  Elena Arystarkhova; Randall K Wetzel; Kathleen J Sweadner
Journal:  Am J Physiol Renal Physiol       Date:  2002-03

2.  Short term effect of aldosterone on Na,K-ATPase cell surface expression in kidney collecting duct cells.

Authors:  V Summa; D Mordasini; F Roger; M Bens; P Y Martin; A Vandewalle; F Verrey; E Féraille
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

3.  The gamma subunit modulates Na(+) and K(+) affinity of the renal Na,K-ATPase.

Authors:  E Arystarkhova; R K Wetzel; N K Asinovski; K J Sweadner
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

4.  Na-K-ATPase isoform (alpha 3, alpha 2, alpha 1) abundance in rat kidney estimated by competitive RT-PCR and ouabain binding.

Authors:  K Lücking; J M Nielsen; P A Pedersen; P L Jørgensen
Journal:  Am J Physiol       Date:  1996-08

5.  Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: possible role of SGK.

Authors:  J Loffing; M Zecevic; E Féraille; B Kaissling; C Asher; B C Rossier; G L Firestone; D Pearce; F Verrey
Journal:  Am J Physiol Renal Physiol       Date:  2001-04

6.  CHIF, a member of the FXYD protein family, is a regulator of Na,K-ATPase distinct from the gamma-subunit.

Authors:  P Béguin; G Crambert; S Guennoun; H Garty; J D Horisberger; K Geering
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

7.  Ouabain and substrate affinities of human Na(+)-K(+)-ATPase alpha(1)beta(1), alpha(2)beta(1), and alpha(3)beta(1) when expressed separately in yeast cells.

Authors:  J Müller-Ehmsen; P Juvvadi; C B Thompson; L Tumyan; M Croyle; J B Lingrel; R H Schwinger; A A McDonough; R A Farley
Journal:  Am J Physiol Cell Physiol       Date:  2001-10       Impact factor: 4.249

8.  Functional differences between alpha subunit isoforms of the rat Na,K-ATPase expressed in Xenopus oocytes.

Authors:  Jean-Daniel Horisberger; Solange Kharoubi-Hess
Journal:  J Physiol       Date:  2002-03-15       Impact factor: 5.182

Review 9.  FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase.

Authors:  Gilles Crambert; Käthi Geering
Journal:  Sci STKE       Date:  2003-01-21

10.  Time course of renal Na-K-ATPase, NHE3, NKCC2, NCC, and ENaC abundance changes with dietary NaCl restriction.

Authors:  Shyama Masilamani; Xiaoyan Wang; Gheun-Ho Kim; Heddwen Brooks; Jakob Nielsen; Soren Nielsen; Kenzo Nakamura; John B Stokes; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2002-10
View more
  12 in total

1.  The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport.

Authors:  Anikó Náray-Fejes-Tóth; Peter M Snyder; Géza Fejes-Tóth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

2.  Cell-specific mRNA alterations in Na+, K+-ATPase α and β isoforms and FXYD in mice treated chronically with carbamazepine, an anti-bipolar drug.

Authors:  Baoman Li; Leif Hertz; Liang Peng
Journal:  Neurochem Res       Date:  2013-02-10       Impact factor: 3.996

3.  The renal cortical collecting duct: a secreting epithelium?

Authors:  Luciana Morla; Alain Doucet; Christine Lamouroux; Gilles Crambert; Aurélie Edwards
Journal:  J Physiol       Date:  2016-08-13       Impact factor: 5.182

Review 4.  Regulation of NaCl transport in the renal collecting duct: lessons from cultured cells.

Authors:  M Bens; C Chassin; A Vandewalle
Journal:  Pflugers Arch       Date:  2006-08-26       Impact factor: 3.657

Review 5.  Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.

Authors:  Mordecai P Blaustein; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-06

6.  HNF1B mutations associate with hypomagnesemia and renal magnesium wasting.

Authors:  Shazia Adalat; Adrian S Woolf; Karen A Johnstone; Andrea Wirsing; Lorna W Harries; David A Long; Raoul C Hennekam; Sarah E Ledermann; Lesley Rees; William van't Hoff; Stephen D Marks; Richard S Trompeter; Kjell Tullus; Paul J Winyard; Janette Cansick; Imran Mushtaq; Harjeeta K Dhillon; Coralie Bingham; Emma L Edghill; Rukshana Shroff; Horia Stanescu; Gerhart U Ryffel; Sian Ellard; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

7.  Vasotocin has the potential to inhibit basolateral Na(+)/K (+)-pump current across isolated skin of tree frog in vitro, via its V(2)-type receptor/cAMP pathway.

Authors:  Makoto Takada; Kayo Fujimaki; Shigeru Hokari
Journal:  J Comp Physiol B       Date:  2008-06-07       Impact factor: 2.200

Review 8.  The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension.

Authors:  Mordecai P Blaustein; Jin Zhang; Ling Chen; Hong Song; Hema Raina; Stephen P Kinsey; Michelle Izuka; Takahiro Iwamoto; Michael I Kotlikoff; Jerry B Lingrel; Kenneth D Philipson; W Gil Wier; John M Hamlyn
Journal:  Hypertension       Date:  2008-12-22       Impact factor: 10.190

Review 9.  Regulation of potassium (K) handling in the renal collecting duct.

Authors:  Wen-Hui Wang; Gerhard Giebisch
Journal:  Pflugers Arch       Date:  2008-10-07       Impact factor: 3.657

10.  Regulation of epithelial Na+ transport by soluble adenylyl cyclase in kidney collecting duct cells.

Authors:  Kenneth R Hallows; Huamin Wang; Robert S Edinger; Michael B Butterworth; Nicholas M Oyster; Hui Li; Jochen Buck; Lonny R Levin; John P Johnson; Núria M Pastor-Soler
Journal:  J Biol Chem       Date:  2009-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.